STOLICK DAVID 4
4 · BRAINSTORM CELL THERAPEUTICS INC · Filed Feb 19, 2010
Insider Transaction Report
Form 4
STOLICK DAVID
Chief Financial Officer
Transactions
- Sale
Common Stock
2010-02-12$0.36/sh−5,000$1,800→ 395,000 total - Sale
Common Stock
2010-02-16$0.36/sh−3,000$1,080→ 392,000 total - Sale
Common Stock
2010-02-16$0.36/sh−140,000$50,400→ 252,000 total - Sale
Common Stock
2010-02-17$0.36/sh−2,000$720→ 250,000 total - Exercise/Conversion
Stock Option (right to buy)
2010-02-12+400,000→ 0 totalExercise: $0.15Exp: 2015-02-13→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The option is fully vested and exercisable